Azathioprine 25 MG Oral Tablet — RxCUI 199310
RxNorm drug concept · Semantic clinical drug
RxCUI 199310
Semantic clinical drug · SCD
● Current RxNorm concept 11 FDA products
31 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI199310
Official nameAzathioprine 25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped11
Package NDCs mapped31
Reported Medicaid activity (SDUD)77,058 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Azathioprine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You're right that it treats two quite different conditions, but the common thread is the immune system. After a kidney transplant, your immune system sees the new kidney as foreign...
- What exactly is azathioprine being used for — it seems like a drug used for very different things?
- Azathioprine is not a quick fix — it typically takes 6 to 8 weeks before you start feeling any improvement, and your doctor will usually give it a full 12 weeks before deciding if...
- How long will it take before I notice it working for my rheumatoid arthritis?
🕸️ Concept Web — How Azathioprine 25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Azathioprine 25 MG Oral Tablet
RxCUI 199310 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Azathioprine
1256IN
-
Azathioprine
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Azathioprine Oral Tablet
370973SCDF -
Azathioprine Oral Product
1155001SCDG -
Azathioprine Pill
1155002SCDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG -
Pill
1151133DFG
-
Azathioprine Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Azathioprine 25 MG
329313SCDC
-
Azathioprine 25 MG
Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Azathioprine 25 MG
SCDC · 329313 -
Azathioprine Oral Tablet
SCDF · 370973 -
Azathioprine Oral Product
SCDG · 1155001 -
Azathioprine Pill
SCDG · 1155002
📦 FDA Products & Package NDCs
11 products · 31 package NDCs
31 package NDCs map to RxCUI 199310 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 67877-0492-01 | 100 TABLET in 1 BOTTLE (67877-492-01) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0492-05 | 500 TABLET in 1 BOTTLE (67877-492-05) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0492-10 | 1000 TABLET in 1 BOTTLE (67877-492-10) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0492-14 | 1 BLISTER PACK in 1 CARTON (67877-492-14) / 14 TABLET in 1... | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0492-38 | 10 BLISTER PACK in 1 CARTON (67877-492-38) / 10 TABLET in 1... | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0493-01 | 100 TABLET in 1 BOTTLE (67877-493-01) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0493-05 | 500 TABLET in 1 BOTTLE (67877-493-05) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0493-10 | 1000 TABLET in 1 BOTTLE (67877-493-10) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0493-38 | 10 BLISTER PACK in 1 CARTON (67877-493-38) / 10 TABLET in 1... | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0494-01 | 100 TABLET in 1 BOTTLE (67877-494-01) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0494-05 | 500 TABLET in 1 BOTTLE (67877-494-05) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0494-10 | 1000 TABLET in 1 BOTTLE (67877-494-10) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0494-38 | 10 BLISTER PACK in 1 CARTON (67877-494-38) / 10 TABLET in 1... | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0495-01 | 100 TABLET in 1 BOTTLE (67877-495-01) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0495-05 | 500 TABLET in 1 BOTTLE (67877-495-05) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0495-10 | 1000 TABLET in 1 BOTTLE (67877-495-10) | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 67877-0495-38 | 10 BLISTER PACK in 1 CARTON (67877-495-38) / 10 TABLET in 1... | Azathioprine | Ascend Laboratories, LLC | 2020-03-29 |
| 68382-0003-01 | 100 TABLET in 1 BOTTLE (68382-003-01) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2007-07-11 |
| 68382-0003-05 | 500 TABLET in 1 BOTTLE (68382-003-05) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2007-07-11 |
| 68382-0118-01 | 100 TABLET in 1 BOTTLE (68382-118-01) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2017-12-02 |
| 68382-0118-05 | 500 TABLET in 1 BOTTLE (68382-118-05) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2017-12-02 |
| 68382-0119-01 | 100 TABLET in 1 BOTTLE (68382-119-01) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2017-12-02 |
| 68382-0119-05 | 500 TABLET in 1 BOTTLE (68382-119-05) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2017-12-02 |
| 68382-0120-01 | 100 TABLET in 1 BOTTLE (68382-120-01) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2017-12-02 |
| 68382-0120-05 | 500 TABLET in 1 BOTTLE (68382-120-05) | Azathioprine | Zydus Pharmaceuticals USA Inc. | 2017-12-02 |
| 70771-1139-01 | 100 TABLET in 1 BOTTLE (70771-1139-1) | Azathioprine | Zydus Lifesciences Limited | 2017-12-02 |
| 70771-1139-05 | 500 TABLET in 1 BOTTLE (70771-1139-5) | Azathioprine | Zydus Lifesciences Limited | 2017-12-02 |
| 70771-1140-01 | 100 TABLET in 1 BOTTLE (70771-1140-1) | Azathioprine | Zydus Lifesciences Limited | 2017-12-02 |
| 70771-1140-05 | 500 TABLET in 1 BOTTLE (70771-1140-5) | Azathioprine | Zydus Lifesciences Limited | 2017-12-02 |
| 70771-1141-01 | 100 TABLET in 1 BOTTLE (70771-1141-1) | Azathioprine | Zydus Lifesciences Limited | 2017-12-02 |
| 70771-1141-05 | 500 TABLET in 1 BOTTLE (70771-1141-5) | Azathioprine | Zydus Lifesciences Limited | 2017-12-02 |
Observed labelers:
Ascend Laboratories, LLC (17) ·
Zydus Pharmaceuticals USA Inc. (8) ·
Zydus Lifesciences Limited (6)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7500 | Azathioprine oral 50mg | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.